Efficacy and Safety of NVP-1203 in Patients With Acute Low Back Pain

A Randomized, Double-blind, Active- and Placebo-controlled, Parallel, Multicenter, Phase II an Exploratory Clinical Trial to Evaluate the Efficacy and Safety NVP-1203 in Patients With Acute Low Back Pain

The purpose of this study is to evaluate the efficacy and safety NVP-1203 in patients with Acute low back pain

This study is a randomized, double-blind, active- and placebo-controlled, parallel, phase II study to evaluate efficacy and safety of NVP-1203 in patients with Acute low back pain

Inclusion Criteria:

• Subjects who have ability to comprehend the contents of study and before participating in trial and have willingness to sign of informed consent in writing
• 19 Years and older
• A patient has symptom of acute low back pain

Exclusion Criteria:

• Subjects who cannot prohibit anti-inflammatory drug or muscle relaxants during clinical trial
• Inadequate subject for the clinical trial by the investigator's decision